Clinical Trials Directory

Trials / Unknown

UnknownNCT02984696

Total Antioxidant Capacity Before and After HRT in Hypotalamic Amenorrhea

Effects of 6 Months of HRT on Total Antioxidant Capacity in Patients Affected by Hypotalamic Amenorrhea

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Catholic University of the Sacred Heart · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Not accepted

Summary

The aim of our study is to investigate the effects of 6 months oh HRT on total anti-oxidant capacity, clinical, endocrine and metabolic features in women affected by hypotalamic amenorrhea. The study group included 20 patients treated with 1 mg of transdermal estradiol daily and 10mg of oral Medroxyprogesterone acetate from 16th to 24th day of therapy for six months. Menstrual pattern, anthropometric parameters, hormonal assays, DXA and bone metabolism parameters are evaluated before and after therapy.

Conditions

Interventions

TypeNameDescription
DRUG1 mg of transdermal estradiol daily and 10mg of oral MPA

Timeline

Start date
2015-03-01
Primary completion
2016-10-01
Completion
2017-12-01
First posted
2016-12-07
Last updated
2016-12-07

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02984696. Inclusion in this directory is not an endorsement.